Skip to content
Projects
Groups
Snippets
Help
Loading...
Help
Submit feedback
Sign in / Register
Toggle navigation
C
cmscenter
Project
Project
Details
Activity
Releases
Cycle Analytics
Repository
Repository
Files
Commits
Branches
Tags
Contributors
Graph
Compare
Charts
Issues
0
Issues
0
List
Board
Labels
Milestones
Merge Requests
0
Merge Requests
0
Wiki
Wiki
Snippets
Snippets
Members
Members
Collapse sidebar
Close sidebar
Activity
Graph
Charts
Create a new issue
Commits
Issue Boards
Open sidebar
吕祺
cmscenter
Commits
688cd9eb
Commit
688cd9eb
authored
Nov 08, 2022
by
吕祺
⛹🏽
Browse files
Options
Browse Files
Download
Email Patches
Plain Diff
自动文章合并|自动图片压缩
parent
d6f7cd89
Changes
1
Pipelines
1
Show whitespace changes
Inline
Side-by-side
Showing
1 changed file
with
20 additions
and
0 deletions
+20
-0
newsList.md
content/newsList.md
+20
-0
No files found.
content/newsList.md
View file @
688cd9eb
---
---
news
:
news
:
-
title
:
帕母医疗完成新一轮数千万美元融资
type
:
医疗健康
createDate
:
2022-11-08T14:36:24.286Z
content
:
>-
近日,帕母医疗宣布完成新一轮数千万美元融资。高榕资本曾于2021年投资帕母医疗,并在此轮融资中继续加注。
帕母医疗选择肺动脉高压领域作为探索的首个未满足临床需求,独创的介入疗法PADN术为患者带来了全新的疗法和解决方案。2021年,PADN产品仅用16天就获得FDA
Breakthrough资质认证,并于2021年12月完成PADN-NMPA注册临床试验所有患者随访。在PADN临床试验方面,帕母医疗在今年7月与美国FDA成功召开了关于PADN全球多中心临床试验的Pre-Sub会议(预审计划会议),标志着公司正式进入FDA
PMA(上市前审批)流程。

目前,PADN全球多中心临床研究也在积极推动中,将为该领域领先的器械疗法及产品的全球商业化奠定更扎实的临床基础。
依托“医工研产商”全价值流程能力的完善整合,帕母医疗打造了孵化创新医疗技术和器械产品“从手术台到市场(Operating Table to
Market)”的OTM平台。在未来长期的战略规划中,帕母医疗的管线还将覆盖心力衰竭以及高血压、糖尿病等一系列慢性病及相关适应症。
-
title
:
祝贺巨子生物港交所主板成功上市
-
title
:
祝贺巨子生物港交所主板成功上市
type
:
上市
type
:
上市
createDate
:
2022-11-08T14:34:27.528Z
createDate
:
2022-11-08T14:34:27.528Z
...
...
Write
Preview
Markdown
is supported
0%
Try again
or
attach a new file
Attach a file
Cancel
You are about to add
0
people
to the discussion. Proceed with caution.
Finish editing this message first!
Cancel
Please
register
or
sign in
to comment